15.09.2015 Views

MISSION

2009 compendium of FAMRI-supported research - Flight Attendant ...

2009 compendium of FAMRI-supported research - Flight Attendant ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

pression/reduction of MCP-1 and long-lasting changes in the balance between PEDF and VEGF. If confirmed,<br />

analysis of blood MCP-1, PEDF, VEGF, quinones, nicotine, and cotinine, as well as analysis of<br />

urine quinones and cotinine, will serve as biomarkers for risk of progression of AMD. Importantly, results<br />

from this study will be directly applicable to other cardiovascular diseases associated with SHS.<br />

A ROLE FOR CATHEPSIN B IN SECOND HAND TOBACCO SMOKE-RELATED VASCULAR DISEASES<br />

Eunok Im, PhD; University of California, Los Angeles; YCSA 2006<br />

SHS increases the risk of ocular diseases. For instance, the vascularized form of age-related macular<br />

degeneration (AMD), one of the malicious vascular diseases that lead to blindness in the elderly, is tightly<br />

associated with SHS. Therefore, identifying regulators of vessel formation will aid in finding early diagnostic<br />

tools and ways to prevent disease progression. Dr. Im discovered that cathepsin B (a lysosomal cysteine<br />

protease) inhibits angiogenesis by suppressing pro-angiogenic factors (vascular endothelial cell growth factor)<br />

and generating anti-angiogenic factors (endostatin). These findings reveal cathepsin B as modulator of<br />

angiogenesis. The goal of Dr. Im’s project is to fully elucidate the mechanism by which cathepsin B modulates<br />

pro- and anti-angiogenic factors, and apply this information to the development of effective approaches<br />

to control SHS-induced angiogenesis. First, it will determine if cathepsin B inhibits angiogenesis. By<br />

comparison of ocular angiogenesis in cathepsin B null mice and control mice expansion of the understandings<br />

of how cathepsin B affects AMD will occur. Second, assessment of the combination of SHS and loss<br />

of cathepsin B will be conducted. Tests will be performed to show if SHS promotes angiogenesis within<br />

the eye and if the combination of SHS and loss of cathepsin B intensifies angiogenesis. Finally, Dr. Im and<br />

colleagues will investigate how cathepsin B regulates the stability of hypoxia-inducible factor 1 subunit a<br />

(HIF-1a), and the outcome of these studies will substantially advance the understanding of how HIF-1a is<br />

controlled. The molecular dissection of angiogenesis will enable better treatment and control of diseases<br />

arising from SHS.<br />

FAMRI Supported Publications<br />

Rhee SH, Im E, Pothoulakis C. Toll-like receptor 5 engagement modulates tumor development and<br />

growth in a mouse xenograft model of human colon cancer. Gastroenterology 2008;135(2):518-528.<br />

VISION<br />

COMPLETED RESEARCH<br />

INFLAMMATION, SMOKING, AND BLINDNESS FROM OCULAR NEOVASCULARIZATION<br />

Scott W. Cousins, MD; Duke University; CIA 2004<br />

Neovascular acute macular degeneration (AMD), typified by choroidal neovascularization and invasion<br />

of abnormal new blood vessels into the retina, has pathogenic features similar to other cardiovascular diseases,<br />

particularly macrophage infiltration. AMD is caused by exposure to cigarette smoke. Dr. Cousins’<br />

research tested the hypothesis that tobacco smoke-related nicotine acts upon circulating monocytes to<br />

induce partially activated monocytes in the blood. The monocytes are recruited to the eye in areas of<br />

choroidal neovascularization and lead to increasingly severe neovascularization via tumor necrosis factor<br />

alpha (TNF-alpha) production (a potent cytotoxic and angiogenic factor). The relationships between neovascular<br />

AMD, blood cotinine levels, and partial activation of blood monocytes were evaluated in a human<br />

case-control study of passive and active smokers versus non-smokers. If a relationship were confirmed, it<br />

would allow blood monocyte activation status to serve as a biomarker for risk of AMD progression. The<br />

results of this study are also applicable to other cardiovascular diseases caused by exposure to cigarette<br />

smoke. A similar study in mice evaluated the capacity of passive and active cigarette smoke (or nicotine) to<br />

affect bone marrow progenitor cells, causing them to differentiate into activated monocytes after smoking<br />

cessation. Results demonstrated that mice exposed to cigarette smoke suffered more severe pathology in<br />

the bone marrow stem cells than those who were not exposed. Dr. Cousins’ results carry an implication of<br />

particular interest to FAMRI, i.e., that flight attendants and others exposed to SHS may have long-term<br />

changes in bone marrow stem cells predisposing them to vascular diseases, including atherosclerosis and<br />

macular degeneration, long after cessation of the cigarette smoke exposure.<br />

P A G E 2 1 5

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!